Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 3Phase 4 2Phase 3 2Phase 2/3 1

Status

Completed 23Unknown 3Withdrawn 1Suspended 1Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 381Breast Neoplasms 364Colorectal Neoplasms 238Stomach Neoplasms 218Carcinoma, Hepatocellular 155Lung Neoplasms 123Neoplasms 120Pancreatic Neoplasms 109Prostatic Neoplasms 100Neoplasm Metastasis 96Recurrence 95Rectal Neoplasms 95Ovarian Neoplasms 90Nasopharyngeal Carcinoma 88Esophageal Neoplasms 82Esophageal Squamous Cell Carcinoma 81Lymphoma, Large B-Cell, Diffuse 79Melanoma 75Small Cell Lung Carcinoma 71Uterine Cervical Neoplasms 70Lymphoma 70Leukemia, Myeloid, Acute 70Brain Neoplasms 69Sarcoma 68Head and Neck Neoplasms 68Squamous Cell Carcinoma of Head and Neck 67Multiple Myeloma 65Carcinoma, Renal Cell 63Triple Negative Breast Neoplasms 61Lymphoma, Non-Hodgkin 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Warts × Clear all
NCT04253912 2021-04-01

Topical 2% Povidone-Iodine Gel in Verruca Vulgaris

Veloce BioPharma LLC

Phase 2 Unknown
90 enrolled

Warts

NCT02640820 2018-02-23

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyproneâ„¢) on the Clearance of Verruca Vulgaris (Common Warts)

RXi Pharmaceuticals, Corp.

Phase 2 Unknown
83 enrolled

Warts, Papillomavirus Infections

NCT00644579 2008-03-27

bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients

NatImmune A/S

Phase 2 Unknown
120 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡